Cd14, Gbp1, and Pla2g2a: Three major candidate genes for experimental IBD identified by combining QTL and microarray analyses

Physiological Genomics

Volumn 25, Issue 3, 2006, Pages 426-434

  De Buhr, Maike F ^a   Mähler, Michael ^a   Geffers, Robert ^b   Hansen, Wiebke ^b   Westendorf, Astrid M ^b   Lauber, Jörg ^b   Buer, Jan ^a,b   Schlegelberger, Brigitte ^a   Hedrich, Hans J ^a   Bleich, Andre ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Gene expression; Inflammatory bowel disease; Mapping; Mouse; Quantitative trait locus

Indexed keywords

BACTERIAL ANTIGEN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD14 GENE; CONTROLLED STUDY; DOWN REGULATION; ENTERITIS; GBP1 GENE; GENE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MICROFLORA; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PLA2G2A GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD14; CELLS, CULTURED; COLITIS, ULCERATIVE; COLON; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOLIPASES A; QUANTITATIVE TRAIT LOCI; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SPECIES SPECIFICITY;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 33646792189     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00022.2005     Document Type: Article

References (54)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, and Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
2. Altschul SF, Gish W, Miller W, Myers EW, and Lipman DJ. Basic local alignment search tool. J Mol Biol 215: 403-410, 1990.
3. Anderson SL, Carton JM, Lou J, Xing L, and Rubin BY. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256: 8-14, 1999.
4. Asseman C, Mauze S, Leach MW, Coffman RL, and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995-1004, 1999.
5. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, and Martinez FD. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20: 976-983, 1999.
6. Bertsch T and Aufenanger J. Phospholipase A2 in inflammatory bowel disease. Gut 41: 859-860, 1997.
7. Bleich A and Mähler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human IBD and Helicobacter-induced gastritis. Pathobiology 72: 293-307, 2005.
8. Bleich A, Mähler M, Most C, Leiter E, Liebler-Tenorio E, Elson C, Hedrich H, Schlegelberger B, and Sundberg J. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15: 865-871, 2004.
9. Briken V, Ruffner H, Schultz U, Schwarz A, Reis LF, Strehlow I, Decker T, and Staeheli P. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol 15: 975-982, 1995.
10. Bristol IJ, Farmer MA, Cong Y, Zheng XX, Strom TB, Elson CO, Sundberg JP, and Leiter EH. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis 6: 290-302, 2000.
11. Cong Y, Brandwein SL, McCabe RP, Lazenby A, Birkenmeier EH, Sundberg JP, and Elson CO. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 187: 855-864, 1998.
12. Cox LA, Birnbaum S, and VandeBerg JL. Identification of candidate genes regulating HDL cholesterol using a chromosomal region expression array. Genome Res 12: 1693-1702, 2002.
13. Elson CO, Sartor RB, Tennyson GS, and Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367, 1995.
14. Farmer MA, Sundberg JP, Bristol IJ, Churchill GA, Li R, Elson CO, and Leiter EH. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci USA 98: 13820-13825, 2001.
15. Funda DP, Tuckova L, Farre MA, Iwase T, Moro I, and Tlaskalova-Hogenova H. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun 69: 3772-3781, 2001.
16. Glazier AM, Nadeau JH, and Aitman TJ. Finding genes that underlie complex traits. Science 298: 2345-2349, 2002.
17. Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, and Sturzl M. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 20: 5568-5577, 2001.
18. Haapamaki MM, Gronroos JM, Nurmi H, Alanen K, Kallajoki M, and Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 40: 95-101, 1997.
19. Haapamaki MM, Gronroos JM, Nurmi H, Alanen K, and Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in Crohn's disease. Am J Gastroenterol 94: 713-720, 1999.
20. Harwig SS, Tan L, Qu XD, Cho Y, Eisenhauer PB, and Lehrer RI. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 95: 603-610, 1995.
21. Hibi T, Ogata H, and Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol 37: 409-417, 2002.
22. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752, 1999.
23. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, and Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823, 1996.
24. Joe B, Letwin NE, Garrett MR, Dhindaw S, Frank B, Sultana R, Verratti K, Rapp JP, and Lee NH. Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array. Physiol Genomics 23: 318-326, 2005.
25. Karp CL, Grupe A, Schadt E, Ewart SL, Keane-Moore M, Cuomo PJ, Kohl J, Wahl L, Kuperman D, Germer S, Aud D, Peltz G, and Wills-Karp M. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immun 1: 221-226, 2000.
26. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, Tang C, Rancourt DE, and Cromlish WA. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 270: 22378-22385, 1995.
27. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, and Epplen JT. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 37: 189-191, 2002.
28. Krimsky M, Yedgar S, Aptekar L, Schwob O, Goshen G, Gruzman A, Sasson S, and Ligumsky M. Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor. Am J Physiol Gastrointest Liver Physiol 285: G586-G592, 2003.
29. Kühn R, Löhler J, Rennick D, Rajewsky K, and Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
30. Labeta MO, Vidal K, Nores JE, Arias M, Vita N, Morgan BP, Guillemot JC, Loyaux D, Ferrara P, Schmid D, Affolter M, Borysiewicz LK, Donnet-Hughes A, and Schiffrin EJ. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med 191: 1807-1812, 2000.
31. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, and Vercelli D. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167: 5838-5844, 2001.
32. Lubeseder-Martellato C, Guenzi E, Jorg A, Topolt K, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzler P, Schwemmle M, Matzen K, Grimm T, Ensoli B, and Sturzl M. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol 161: 1749-1759, 2002.
33. Min-induced intestinal neoplasia. Cell 81: 957-966, 1995.
34. Mähler M and Leiter EH. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis 8: 347-355, 2002.
35. Mähler M, Most C, Schmidtke S, Sundberg JP, Li R, Hedrich HJ, and Churchill GA. Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis. Genomics 80: 274-282, 2002.
36. Meijssen MA, Brandwein SL, Reinecker HC, Bhan AK, and Podolsky DK. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am J Physiol Gastrointest Liver Physiol 274: G472-G479, 1998.
37. Moolenbeek C and Ruitenberg EJ. The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab Anim 15: 57-59, 1981.
38. Moser AR, Dove WF, Roth KA, and Gordon JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116: 1517-1526, 1992.
39. Muroi M, Ohnishi T, and Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J Biol Chem 277: 42372-42379, 2002.
40. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, and Illgen-Wilcke B. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36: 20-42, 2002.
41. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, and Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 37: 699-704, 2002.
42. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, and Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170: 3977-3985, 2003.
43. Podolsky DK. Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
44. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, and Herrmann C. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403: 567-571, 2000.
45. Qi H, Denning TL, and Soong L. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect Immun 71: 3337-3342, 2003.
46. Re F and Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699, 2001.
47. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, and Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231, 1998.
48. Staeheli P, Prochazka M, Steigmeier PA, and Haller O. Genetic control of interferon action: mouse strain distribution and inheritance of an induced protein with guanylate-binding property. Virology 137: 135-142, 1984.
49. Sundberg JP, Elson CO, Bedigian H, and Birkenmeier EH. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 107: 1726-1735, 1994.
50. Tomita M, Ohkubo R, and Hayashi M. Lipopolysaccharide transport system across colonic epithelial cells in normal and infective rat. Drug Metab Pharmacokinet 19: 33-40, 2004.
51. Uehara A, Sugawara S, Watanabe K, Echigo S, Sato M, Yamaguchi T, and Takada H. Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Diagn Lab Immunol 10: 286-292, 2003.
52. Wenneras C, Ave P, Huerre M, Arondel J, Ulevitch R, Mathison J, and Sansonetti P. Blockade of CD14 aggravates experimental shigellosis. J Endotoxin Res 7: 442-446, 2001.
53. Wenneras C, Ave P, Huerre M, Arondel J, Ulevitch RJ, Mathison JC, and Sansonetti P. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 164: 3214-3221, 2000.
54. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, and Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.